First Trust Advisors LP Acadia Pharmaceuticals Inc Transaction History

First Trust Advisors LP

$95 Billion
Q2 2024

A detailed history of First Trust Advisors LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, First Trust Advisors LP holds 2,068,320 shares of ACAD stock, worth $30.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,068,320

Previous 1,648,798 25.44%

Holding current value

$30.6 Million

Previous $30.5 Million 10.25%

% of portfolio

0.04%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.62 - $18.42 $6.13 Million - $7.73 Million	419,522 Added 25.44%	2,068,320 $33.6 Million
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $2.29 Million - $3.97 Million	-128,509 Reduced 7.23%	1,648,798 $30.5 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $3.09 Million - $4.72 Million	148,526 Added 9.12%	1,777,307 $55.6 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $18.2 Million - $29.3 Million	-875,664 Reduced 34.96%	1,628,781 $33.9 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $3.74 Million - $5.39 Million	-210,040 Reduced 7.74%	2,504,445 $60 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $2.74 Million - $3.51 Million	-167,876 Reduced 5.82%	2,714,485 $51.1 Million
Q4 2022 Feb 09, 2023	SELL	$14.2 - $18.63 $532,485 - $698,606	-37,499 Reduced 1.28%	2,882,361 $45.9 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $10.6 Million - $13.7 Million	748,618 Added 34.48%	2,919,860 $47.8 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $2.09 Million - $4.38 Million	-160,912 Reduced 6.9%	2,171,242 $30.6 Million
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $21.4 Million - $28.1 Million	-1,020,729 Reduced 30.44%	2,332,154 $56.5 Million
Q4 2021 Feb 08, 2022	BUY	$16.79 - $27.09 $12.6 Million - $20.3 Million	750,420 Added 28.83%	3,352,883 $78.3 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $5.08 Million - $7.98 Million	-322,174 Reduced 11.02%	2,602,463 $43.2 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $26.1 Million - $36.9 Million	1,347,516 Added 85.44%	2,924,637 $71.3 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $1.14 Million - $2.5 Million	-45,455 Reduced 2.8%	1,577,121 $40.7 Million
Q4 2020 Feb 02, 2021	SELL	$41.04 - $56.79 $3.88 Million - $5.37 Million	-94,555 Reduced 5.51%	1,622,576 $86.7 Million
Q3 2020 Nov 05, 2020	BUY	$36.42 - $57.0 $10.8 Million - $16.9 Million	296,883 Added 20.9%	1,717,131 $70.8 Million
Q2 2020 Jul 22, 2020	SELL	$39.26 - $52.73 $632,125 - $849,005	-16,101 Reduced 1.12%	1,420,248 $68.8 Million
Q1 2020 May 06, 2020	BUY	$31.65 - $46.87 $249,686 - $369,757	7,889 Added 0.55%	1,436,349 $60.7 Million
Q4 2019 Feb 03, 2020	SELL	$36.21 - $51.4 $39.9 Million - $56.6 Million	-1,101,903 Reduced 43.55%	1,428,460 $61.1 Million
Q3 2019 Nov 04, 2019	SELL	$22.22 - $44.01 $37.5 Million - $74.3 Million	-1,688,706 Reduced 40.03%	2,530,363 $91.1 Million
Q2 2019 Jul 30, 2019	SELL	$23.32 - $28.12 $13.9 Million - $16.8 Million	-596,707 Reduced 12.39%	4,219,069 $113 Million
Q1 2019 May 09, 2019	BUY	$16.17 - $27.38 $10.9 Million - $18.5 Million	677,051 Added 16.36%	4,815,776 $129 Million
Q4 2018 Feb 07, 2019	SELL	$14.32 - $22.92 $24.8 Million - $39.7 Million	-1,731,968 Reduced 29.5%	4,138,725 $66.9 Million
Q3 2018 Oct 25, 2018	BUY	$13.03 - $21.81 $42.6 Million - $71.3 Million	3,267,247 Added 125.5%	5,870,693 $122 Million
Q2 2018 Aug 02, 2018	BUY	$15.07 - $22.34 $12.7 Million - $18.8 Million	840,425 Added 47.67%	2,603,446 $39.8 Million
Q1 2018 Apr 23, 2018	BUY	$22.47 - $32.33 $5.39 Million - $7.76 Million	239,909 Added 15.75%	1,763,021 $39.6 Million
Q4 2017 Feb 08, 2018	BUY	$26.84 - $39.14 $8.39 Million - $12.2 Million	312,671 Added 25.83%	1,523,112 $45.9 Million
Q3 2017 Oct 24, 2017	BUY	$29.49 - $38.37 $35.7 Million - $46.4 Million	1,210,441	1,210,441 $45.6 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Acadia Pharmaceuticals Inc Transaction History